Screener
RSHO vs CANC
Tema American Reshoring ETF vs Tema Oncology ETF
Key differences
- RSHO follows a active selection strategy; CANC uses index tracking.
Side-by-side comparison
| RSHO | CANC | |
|---|---|---|
| Annual cost (TER) | 0.75% | 0.75% |
| Fund size (AUM) | $263M | $176M |
| Since | 2023 | 2023 |
| Dividend yield | 0.23% | 0.05% |
| Asset class | equity | equity |
| Region | north america | — |
| Strategy | active selection | index tracking |
| CAGR 1Y | +52.3% | +57.7% |
| CAGR 3Y | +30.9% | N/A |
| CAGR 5Y | N/A | N/A |
| Sharpe 3Y | 1.15 | N/A |
| Volatility 1Y | 23.51% | 23.33% |
| Max drawdown | -27.31% | -28.17% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to RSHO and CANC
Explore further